Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1986 1
1997 1
2008 3
2009 1
2010 3
2011 1
2012 3
2013 6
2014 6
2015 5
2016 14
2017 16
2018 14
2019 18
2020 20
2021 29
2022 33
2023 20
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Doysa
Page 1
Did you mean de zoysa r[au] (5 results)?
Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study.
Walli-Attaei M, Rosengren A, Rangarajan S, Breet Y, Abdul-Razak S, Sharief WA, Alhabib KF, Avezum A, Chifamba J, Diaz R, Gupta R, Hu B, Iqbal R, Ismail R, Kelishadi R, Khatib R, Lang X, Li S, Lopez-Jaramillo P, Mohan V, Oguz A, Palileo-Villanueva LM, Poltyn-Zaradna K, R SP, Pinnaka LVM, Serón P, Teo K, Verghese ST, Wielgosz A, Yeates K, Yusuf R, Anand SS, Yusuf S; PURE investigators. Walli-Attaei M, et al. Among authors: r sp. Lancet. 2022 Sep 10;400(10355):811-821. doi: 10.1016/S0140-6736(22)01441-6. Lancet. 2022. PMID: 36088949 Clinical Trial.
Fish melanocortin system.
Cerdá-Reverter JM, Agulleiro MJ, R RG, Sánchez E, Ceinos R, Rotllant J. Cerdá-Reverter JM, et al. Among authors: r rg. Eur J Pharmacol. 2011 Jun 11;660(1):53-60. doi: 10.1016/j.ejphar.2010.10.108. Epub 2011 Jan 3. Eur J Pharmacol. 2011. PMID: 21208603 Review.
Toxic impacts and industrial potential of graphene.
Patel TN, R P, Vashi Y, Bhattacharya P. Patel TN, et al. Among authors: r p. J Environ Sci Health C Toxicol Carcinog. 2020;38(3):269-297. doi: 10.1080/26896583.2020.1812335. Epub 2020 Sep 8. J Environ Sci Health C Toxicol Carcinog. 2020. PMID: 32897810 Review.
Due to its flexible nature graphene and its derivatives have several significant prospects extending from electronics to life sciences and drug delivery systems. In this review, we enlist some of the toxic effects of graphene family nanomaterials (GFNs) in various a …
Due to its flexible nature graphene and its derivatives have several significant prospects extending from electronics to life sciences and …
Human orphan cytochromes P450: An update.
D MO, C TZ, R SP. D MO, et al. Among authors: r sp. Curr Drug Metab. 2022 Dec 9. doi: 10.2174/1389200224666221209153032. Online ahead of print. Curr Drug Metab. 2022. PMID: 36503398
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study.
Ali SS, R N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK, Ziade N, Velikova T, Milchert M, Jagtap K, Parodis I, Edgar Gracia-Ramos A, Cavagna L, Kuwana M, Knitza J, Chen YM, Makol A, Agarwal V, Patel A, Pauling JD, Wincup C, Barman B, Zamora Tehozol EA, Rojas Serrano J, La Torre IG, Colunga-Pedraza IJ, Merayo-Chalico J, Chibuzo OC, Katchamart W, Goo PA, Shumnalieva R, Hoff LS, El Kibbi L, Halabi H, Vaidya B, Shaharir SS, Hasan ATMT, Dey D, Gutiérrez CET, Caballero-Uribe CV, Lilleker JB, Salim B, Gheita T, Chatterjee T, Distler O, Saavedra MA, Chinoy H, Agarwal V, Aggarwal R, Gupta L; COVAD Study Group. Ali SS, et al. Among authors: r n. Rheumatology (Oxford). 2023 Sep 1;62(9):e263-e268. doi: 10.1093/rheumatology/kead149. Rheumatology (Oxford). 2023. PMID: 37004201 No abstract available.
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study.
Ziade N, Aoude M, Hmamouchi I, R N, Lilleker JB, Sen P, Joshi M, Agarwal V, Kardes S, Day J, Makol A, Milchert M, Gheita T, Salim B, Velikova T, Edgar Gracia-Ramos A, Parodis I, Nikiphorou E, Chatterjee T, Tan AL, Saavedra MA, Shinjo SK, Knitza J, Kuwana M, Nune A, Cavagna L, Distler O, Chinoy H, Agarwal V, Aggarwal R, Gupta L; COVAD Study Group. Ziade N, et al. Among authors: r n. Rheumatology (Oxford). 2024 Mar 1;63(3):657-664. doi: 10.1093/rheumatology/kead250. Rheumatology (Oxford). 2024. PMID: 37228012
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys.
R N, Sen P, Griger Z, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK, Ziade N, Velikova T, Milchert M, Jagtap K, Parodis I, Gracia-Ramos AE, Cavagna L, Kuwana M, Knitza J, Chen YM, Makol A, Agarwal V, Patel A, Pauling JD, Wincup C, Barman B, Zamora Tehozol EA, Rojas Serrano J, García-De La Torre I, Colunga-Pedraza IJ, Merayo-Chalico J, Chibuzo OC, Katchamart W, Akarawatcharangura Goo P, Shumnalieva R, Hoff LS, El Kibbi L, Halabi H, Vaidya B, Shaharir SS, Hasan ATMT, Dey D, Toro Gutiérrez CE, Caballero-Uribe CV, Lilleker JB, Salim B, Gheita T, Chatterjee T, Distler O, Saavedra MA, Chinoy H, Agarwal V, Aggarwal R, Gupta L; COVAD Study Group. R N, et al. Rheumatology (Oxford). 2024 Jan 4;63(1):127-139. doi: 10.1093/rheumatology/kead180. Rheumatology (Oxford). 2024. PMID: 37084267
Drug Therapy in Cognitive Disorders and Its Effects on Oral Health.
Ahmed SE, Begum R, Kumar AS, M A, R V, I V. Ahmed SE, et al. Among authors: r v. Cureus. 2022 Jul 24;14(7):e27194. doi: 10.7759/cureus.27194. eCollection 2022 Jul. Cureus. 2022. PMID: 36039264 Free PMC article. Review.
This article gives an insight into the management of dementia and Alzheimer's disease and also an update on the drug therapies for AD and outlines their implications on oral health....
This article gives an insight into the management of dementia and Alzheimer's disease and also an update on the drug therapies for AD …
Endoplasmic reticulum stress: A master regulator of metabolic syndrome.
Mohan S, R PRM, Brown L, Ayyappan P, G RK. Mohan S, et al. Among authors: r prm. Eur J Pharmacol. 2019 Oct 5;860:172553. doi: 10.1016/j.ejphar.2019.172553. Epub 2019 Jul 17. Eur J Pharmacol. 2019. PMID: 31325433 Review.
The initial studies with these chemical chaperones are promising, but detailed studies are required to define their efficacy and adverse effects during therapeutic use in humans....
The initial studies with these chemical chaperones are promising, but detailed studies are required to define their efficacy and adverse …
169 results